GGTLC1 and metabolic dysfunction-associated steatotic liver disease: Patients with NAFLD exhibited significantly higher levels of Systolic/Diastolic blood pressure (S/DBP), BMI, waist circumference, hip circumference, LSM, triglycerides (TG), non-HDL-C, TC, low-density lipoprotein cholesterol (LDL-C), alanine aminotransferase (ALT), gamma-glutamyl transpeptidase (GGT), aspartate aminotransferase (AST), fast glucose, fast insulin, HbA1c, PLT, CRP, SUA; conversely, those with NAFLD had significantly lower HDL-C and total bilirubin(TBIL)values (P < 0.001 for each).